Home> Products> extended release tablet form

{ "products": [ { "_id": "6a05af2f5973eae52aa766f8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "gabapentin sustained release tablets 450 mg", "description": "Introduction to Gabapentin Sustained Release Tablets 450 mg\n\nGabapentin Sustained Release Tablets 450 mg are widely prescribed for the management of nerve-related pain and certain neurological conditions. These tablets are formulated with sustained-release technology, which allows the medicine to release gradually in the body over time. This helps maintain a stable therapeutic effect and reduces the need for frequent dosing.\n\nPatients suffering from neuropathic pain, diabetic nerve pain, post-herpetic neuralgia, or other nerve disorders often look for long-lasting and effective relief. Gabapentin Sustained Release Tablets 450 mg are designed to provide extended support throughout the day while improving patient comfort and compliance.\n\nThe sustained-release formulation is especially beneficial for individuals who require continuous symptom management without experiencing sudden fluctuations in medicine levels. Healthcare professionals frequently recommend this dosage because of its balanced effectiveness and convenient administration.\n\nWhat Are Gabapentin Sustained Release Tablets 450 mg?\n\nGabapentin Sustained Release Tablets 450 mg contain gabapentin as the active pharmaceutical ingredient. Gabapentin belongs to a class of medicines known as anticonvulsants or nerve pain modulators. It is commonly used to control abnormal nerve signals in the body.\n\nUnlike immediate-release formulations, sustained-release tablets slowly release the medication over several hours. This controlled release mechanism helps in maintaining prolonged relief from nerve pain and discomfort.\n\nThese tablets are often prescribed for:\n\nNeuropathic pain\nDiabetic neuropathy\nPost-herpetic neuralgia\nFibromyalgia-related nerve discomfort\nCertain seizure disorders\nChronic nerve-related pain conditions\n\nBecause nerve pain can significantly affect daily life, sleep quality, and mobility, many patients prefer sustained-release formulations for their consistent action and reduced dosing frequency.\n\nHow Gabapentin Sustained Release Tablets 450 mg Work\n\nGabapentin works by affecting the transmission of nerve signals in the central nervous system. In nerve pain conditions, damaged nerves may send abnormal pain signals to the brain. Gabapentin helps calm these overactive nerve impulses and reduces the sensation of pain, burning, tingling, or numbness.\n\nThe sustained-release technology ensures that the medicine is gradually absorbed into the bloodstream. This offers several advantages:\n\nLonger-lasting pain relief\nReduced fluctuations in drug levels\nBetter nighttime symptom control\nImproved patient adherence\nLower frequency of dosing\n\nPatients with chronic neuropathic conditions often benefit from the steady therapeutic action provided by Gabapentin Sustained Release Tablets 450 mg.\n\nUses of Gabapentin Sustained Release Tablets 450 mg\n\nGabapentin Sustained Release Tablets 450 mg are commonly used in the treatment and management of multiple conditions related to nerve dysfunction.\n\n1. Neuropathic Pain\n\nNeuropathic pain develops due to nerve damage or malfunction. Patients may experience sharp pain, burning sensations, tingling, or electric shock-like discomfort. Gabapentin helps reduce these symptoms effectively.\n\n2. Diabetic Neuropathy\n\nPeople with diabetes may develop nerve damage over time, especially in the legs and feet. Gabapentin Sustained Release Tablets 450 mg help control pain, numbness, and discomfort associated with diabetic neuropathy.\n\n3. Post-Herpetic Neuralgia\n\nAfter shingles infection, some patients continue to experience persistent nerve pain. Gabapentin is commonly prescribed to manage this condition and improve quality of life.\n\n4. Partial Seizures\n\nGabapentin may also be used as an adjunct therapy in certain seizure disorders under medical supervision.\n\n5. Fibromyalgia and Chronic Pain Disorders\n\nSome healthcare professionals recommend gabapentin for chronic pain syndromes involving nerve sensitivity and persistent discomfort.\n\nBenefits of Gabapentin Sustained Release Tablets 450 mg\nLong-Lasting Relief\n\nThe sustained-release formulation provides extended symptom management throughout the day and night.\n\nImproved Patient Convenience\n\nReduced dosing frequency makes it easier for patients to follow their treatment schedule consistently.\n\nStable Therapeutic Effect\n\nThe gradual release mechanism helps maintain balanced medicine levels in the body.\n\nBetter Sleep Quality\n\nMany patients with nerve pain struggle to sleep because of discomfort. Gabapentin may help reduce nighttime pain and improve rest.\n\nEnhanced Daily Functioning\n\nBy controlling chronic nerve pain, patients can experience better mobility, comfort, and overall quality of life.\n\nReduced Sudden Drug Peaks\n\nSustained-release tablets help avoid abrupt rises and falls in medicine concentration, contributing to smoother symptom control.\n\nWho May Need Gabapentin Sustained Release Tablets 450 mg?\n\nGabapentin Sustained Release Tablets 450 mg may be recommended for:\n\nAdults with chronic nerve pain\nPatients suffering from diabetic neuropathy\nIndividuals with post-shingles nerve pain\nPatients requiring prolonged pain control\nIndividuals experiencing tingling, numbness, or burning sensations\nPatients needing supportive seizure management\n\nA healthcare professional will determine the appropriate dosage and duration depending on the patient’s condition and response to therapy.\n\nHow to Take Gabapentin Sustained Release Tablets 450 mg\n\nPatients should always follow the dosage instructions provided by their healthcare provider.\n\nGeneral administration guidelines include:\n\nSwallow the tablet whole with water\nDo not crush, chew, or break the tablet\nTake the medicine at the same time daily\nCan be taken with or without food, depending on medical advice\nAvoid missing doses for consistent symptom control\n\nThe sustained-release mechanism works properly only when the tablet is taken intact.\n\nPossible Side Effects of Gabapentin Sustained Release Tablets 450 mg\n\nLike all medicines, Gabapentin Sustained Release Tablets 450 mg may cause some side effects in certain individuals. Most side effects are mild to moderate and may decrease as the body adjusts to the medication.\n\nCommon side effects may include:\n\nDizziness\nDrowsiness\nFatigue\nSleepiness\nCoordination problems\nBlurred vision\nSwelling in hands or feet\nDry mouth\n\nPatients should seek medical attention if they experience severe allergic reactions, breathing difficulties, or unusual behavioral changes.\n\nPrecautions and Safety Information\n\nBefore taking Gabapentin Sustained Release Tablets 450 mg, patients should inform their healthcare provider about any existing medical conditions or ongoing treatments.\n\nImportant precautions include:\n\nUse cautiously in kidney disorders\nAvoid alcohol consumption during treatment\nDo not suddenly stop the medication without medical advice\nInform the doctor about pregnancy or breastfeeding\nUse caution while driving or operating machinery if dizziness occurs\n\nFollowing medical guidance helps ensure safe and effective treatment outcomes.\n\nWhy Choose Gabapentin Sustained Release Tablets 450 mg?\n\nPatients and healthcare providers often prefer Gabapentin Sustained Release Tablets 450 mg because of their reliable symptom management and patient-friendly formulation.\n\nKey reasons include:\n\nExtended-release technology\nConsistent pain management\nConvenient once or twice daily dosing\nSuitable for chronic conditions\nImproved treatment adherence\nEffective management of neuropathic symptoms\n\nThe formulation is particularly useful for patients seeking long-duration relief from persistent nerve pain.\n\nStorage Instructions\n\nProper storage helps maintain the quality and effectiveness of the medicine.\n\nStore in a cool and dry place\nKeep away from direct sunlight\nProtect from moisture\nKeep out of reach of children\nDo not use expired medication\n\nAlways check packaging instructions for specific storage recommendations.\n\nConclusion\n\nGabapentin Sustained Release Tablets 450 mg are an effective and widely trusted option for managing neuropathic pain and related neurological conditions. With sustained-release technology, these tablets provide prolonged relief, stable symptom control, and improved patient convenience.\n\nWhether used for diabetic neuropathy, post-herpetic neuralgia, chronic nerve pain, or supportive seizure therapy, Gabapentin Sustained Release Tablets 450 mg helps patients achieve better comfort and daily functioning. Their long-lasting action, convenient dosing schedule, and reliable therapeutic effect make them a preferred choice for many healthcare professionals and patients alike.", "price": 375.0, "discountamount": 112.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2421, "imageuri": "https://productimages.withfloats.com/actual/6a05af338d715b31cefe444d.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6a05af338d715b31cefe444d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-05-14T11:17:03.427Z", "updatedon": "2026-05-14T11:17:03.427Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gabapentin-sustained-release-tablets-450-mg/2421", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Stargab SR 450", "category": "NEUROLOGY RANGE", "tags": [ "gabapentin sustained release tablets 450 mg", "Gabapentin Sustained Release Tablets 450 mg", "Gabapentin 450 mg Neuropathic Pain Treatment Tablets", "Nerve Pain Relief Medicine Gabapentin 450 mg", "Gabapentin SR 450 mg Prescription Medicine", "Sustained Release Gabapentin Tablets 450 mg", "Gabapentin 450 mg Product Image", "Gabapentin SR 450 mg Pharmaceutical Medicine", "Gabapentin 450 mg Extended Release Tablets", "Oral Gabapentin Sustained Release Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69ba6804c567eee0a8f28929", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "metformin hydrochloride prolonged release and glimepiride tablets", "description": "Managing blood sugar levels effectively is essential for leading a healthy and active life, especially for individuals living with Type 2 Diabetes. With changing lifestyles, unhealthy eating habits, and rising stress levels, diabetes has become increasingly common. To address this, combination therapies like SEIZMET G3 850 offer a powerful and balanced approach to blood sugar control.\n\nThis article provides a detailed, human-friendly, and SEO-optimized guide to Metformin Hydrochloride Prolonged Release and Glimepiride Tablets, marketed under the brand name SEIZMET G3 850.\n\nWhat is SEIZMET G3 850?\n\nSEIZMET G3 850 is a combination anti-diabetic medication that contains:\n\nMetformin Hydrochloride (Prolonged Release) – 850 mg\n\nGlimepiride – 3 mg\n\nThis dual-action formula is designed to control high blood sugar levels in patients with Type 2 Diabetes by targeting different mechanisms in the body.\n\nHow Does SEIZMET G3 850 Work?\n\nThis medicine works through a combination of two powerful components:\n\n1. Metformin (Prolonged Release)\n\nMetformin helps:\n\nReduce glucose production in the liver\n\nImprove insulin sensitivity\n\nEnhance glucose absorption by cells\n\nThe prolonged-release formulation ensures gradual and sustained action, reducing side effects and improving patient compliance.\n\n2. Glimepiride\n\nGlimepiride works by:\n\nStimulating the pancreas to release insulin\n\nImproving the body’s ability to utilize insulin\n\nTogether, these ingredients provide comprehensive blood sugar control throughout the day.\n\nUses of SEIZMET G3 850\n\nSEIZMET G3 850 is primarily used for:\n\n✔ Management of Type 2 Diabetes\n\nIt helps control high blood sugar levels when diet and exercise alone are not sufficient.\n\n✔ Improving Glycemic Control\n\nIt stabilizes blood glucose fluctuations and prevents sudden spikes.\n\n✔ Reducing Risk of Complications\n\nProper diabetes management reduces the risk of:\n\nHeart disease\n\nKidney damage\n\nNerve problems\n\nVision issues\n\nKey Benefits of SEIZMET G3 850\n1. Dual Action Formula\n\nCombines two effective drugs to target diabetes from multiple angles.\n\n2. Sustained Blood Sugar Control\n\nThe prolonged-release metformin ensures steady glucose control throughout the day.\n\n3. Improved Insulin Function\n\nEnhances insulin sensitivity and promotes better glucose utilization.\n\n4. Convenient Dosage\n\nSingle tablet combination reduces pill burden and improves adherence.\n\n5. Weight Neutral Effect\n\nMetformin may help prevent weight gain often associated with diabetes medications.\n\n6. Cardiovascular Protection\n\nHelps reduce the risk of heart-related complications in diabetic patients.\n\nDosage and Administration\n\nAlways take SEIZMET G3 850 as prescribed by your doctor\n\nUsually taken once daily with meals\n\nSwallow the tablet whole—do not crush or chew\n\nMaintain a balanced diet and regular exercise routine\n\nPossible Side Effects\n\nLike all medications, SEIZMET G3 850 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects:\n\nNausea\n\nDiarrhea\n\nStomach discomfort\n\nHeadache\n\nDizziness\n\nThese are usually mild and improve as your body adjusts to the medication.\n\nSerious Side Effects (Rare but Important):\n\nLow blood sugar (hypoglycemia)\n\nLactic acidosis (a rare but serious condition linked to metformin)\n\nAllergic reactions (rash, swelling, itching)\n\nSeek immediate medical attention if you experience severe symptoms.\n\nPrecautions and Warnings\n\nBefore taking SEIZMET G3 850, inform your doctor if you have:\n\nKidney or liver disease\n\nHeart conditions\n\nHistory of alcohol abuse\n\nVitamin B12 deficiency\n\nImportant Tips:\n\nAvoid excessive alcohol consumption\n\nMonitor blood sugar regularly\n\nFollow a diabetic-friendly diet\n\nInform your doctor about other medications\n\nWho Should Avoid This Medicine?\n\nSEIZMET G3 850 may not be suitable for:\n\nPatients with severe kidney disease\n\nIndividuals with Type 1 Diabetes\n\nPregnant or breastfeeding women (unless prescribed)\n\nPeople with known allergies to its components\n\nLifestyle Tips for Better Results\n\nMedication works best when combined with a healthy lifestyle:\n\n✔ Balanced Diet\nInclude:\nWhole grains\nVegetables\n\nLean protein\n\nAvoid sugary and processed foods.\n\n✔ Regular Exercise\n\nAt least 30 minutes of daily activity helps improve insulin sensitivity.\n\n✔ Stress Management\n\nStress can increase blood sugar levels—practice meditation or yoga.\n\n✔ Routine Checkups\n\nRegular monitoring ensures better control and prevents complications.\n\nWhy Choose the SEIZMET G3 850?\n\nChoosing the right medication is crucial in diabetes management. SEIZMET G3 850 stands out because:\n\nIt combines trusted and proven ingredients\n\nOffers long-lasting glucose control\n\nImproves overall metabolic health\n\nSupports a better quality of life\n\nConclusion\nLiving with type 2 diabetes can be challenging, but with the right treatment and lifestyle choices, it can be effectively managed.", "price": 112.0, "discountamount": 34.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2338, "imageuri": "https://productimages.withfloats.com/actual/69ba680714005fb7b0e65883.png", "tileimageuri": "https://productimages.withfloats.com/tile/69ba680714005fb7b0e65883.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-18T08:53:24.979Z", "updatedon": "2026-03-18T09:03:56.284Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metformin-hydrochloride-prolonged-release-and-glimepiride-tablets/2338", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET G3 850", "category": "DIABETIC RANGE", "tags": [ "metformin prolonged release and glimepiride tablets uses", "glimepiride with metformin sr tablets benefits", "metformin hydrochloride pr and glimepiride combination", "metformin sr and glimepiride tablets dosage guide", "glimepiride metformin tablets for type 2 diabetes", "metformin glimepiride combination therapy benefits", "metformin glimepiride tablets for sugar control", "tablets for type 2 diabetes control india", "best medicine for high blood sugar type 2", "combination tablets for diabetes management", "what is metformin hydrochloride prolonged release", "how to control blood sugar with oral tablets", "order metformin glimepiride tablets online india", "glimepiride and metformin tablets manufacturer india", "where to buy diabetes tablets metformin glimepiride", "prescription tablets for type 2 diabetes buy online", "metformin 850 glimepiride 3mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69a9837a9c219e2cff873568", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "dapagliflozin glimepiride metformin tablet", "description": "Composition: Dapagliflozin 10 mg + Glimepiride 2 mg + Metformin Hydrochloride 500 mg (Extended Release)\n\nManaging type 2 diabetes requires a balanced approach that includes proper medication, healthy lifestyle choices, and regular monitoring of blood sugar levels. Modern diabetes management often involves combination therapies that target blood glucose control through multiple mechanisms. One such effective combination medicine is GLIDAPAFLOZIN TRIO 2.\n\nThis medication contains three well-known antidiabetic agents—Dapagliflozin, Glimepiride, and Metformin Hydrochloride in an extended-release formulation. Together, these medicines work in different ways to help control blood sugar levels effectively in adults with type 2 diabetes.\n\nThis article provides a comprehensive overview of the product, its uses, benefits, possible side effects, and important information patients should know before using it.\n\nProduct Overview\n\nGLIDAPAFLOZIN TRIO 2 is a triple-combination oral antidiabetic tablet designed to help manage blood glucose levels in patients diagnosed with Type 2 Diabetes.\n\nEach tablet contains:\n\nDapagliflozin 10 mg\n\nGlimepiride 2 mg\n\nMetformin Hydrochloride 500 mg (Extended Release)\n\nThese ingredients work together to reduce high blood sugar levels through complementary mechanisms, helping patients achieve better glycemic control.\n\nCombination therapy like this is commonly recommended when a single medication alone is not sufficient to manage blood glucose levels.\n\nHow the Medicine Works\n\nThe three active ingredients in GLIDAPAFLOZIN TRIO 2 work through different pathways in the body.\n\n1. Dapagliflozin\n\nDapagliflozin belongs to a class of drugs known as SGLT2 inhibitors. It works by helping the kidneys remove excess glucose from the body through urine. This reduces blood sugar levels and may also provide additional cardiovascular and kidney benefits in some patients.\n\n2. Glimepiride\n\nGlimepiride stimulates the pancreas to release more insulin. Insulin is the hormone responsible for moving glucose from the bloodstream into cells where it can be used as energy.\n\n3. Metformin Hydrochloride (Extended Release)\n\nMetformin Hydrochloride helps lower blood sugar by reducing glucose production in the liver and improving insulin sensitivity in the body. The extended-release formulation ensures a steady release of the medicine over time, improving tolerance and effectiveness.\n\nTogether, these three medicines provide a comprehensive approach to blood sugar management.\n\nUses of GLIDAPAFLOZIN TRIO 2\n\nGLIDAPAFLOZIN TRIO 2 is primarily prescribed for the management of Type 2 Diabetes in adults.\n\nMain Uses\n\nBlood Sugar Control\nThe medication helps reduce high blood glucose levels in patients whose diabetes is not adequately controlled with diet, exercise, or single-drug therapy.\n\nImproving Insulin Function\nIt improves the body’s response to insulin and helps regulate glucose metabolism.\n\nPreventing Diabetes Complications\nProper blood sugar control reduces the risk of long-term complications such as nerve damage, kidney disease, vision problems, and cardiovascular issues.\n\nSupporting Weight and Metabolic Health\nThe presence of dapagliflozin may help some patients experience mild weight reduction and improved metabolic balance.\n\nKey Benefits\n\nThe combination of three effective antidiabetic agents offers several important benefits.\n\n1. Triple Mechanism Action\n\nThe medicine works through three complementary mechanisms, targeting multiple causes of high blood sugar.\n\n2. Better Glycemic Control\n\nPatients often achieve improved HbA1c levels compared to single-drug therapy.\n\n3. Reduced Risk of Long-Term Complications\n\nMaintaining controlled blood sugar levels helps prevent complications associated with diabetes.\n\n4. Convenient Single Tablet Therapy\n\nInstead of taking multiple medicines separately, patients can manage their treatment with a single tablet, improving medication adherence.\n\n5. Extended Release Technology\n\nThe extended-release formulation of Metformin Hydrochloride ensures gradual drug release, reducing stomach discomfort and improving patient tolerance.\n\n6. Improved Energy and Daily Functioning\n\nProper blood sugar control helps patients feel more energetic and maintain better overall health.\n\nPossible Side Effects\n\nLike all medications, GLIDAPAFLOZIN TRIO 2 may cause some side effects. However, not everyone experiences them.\n\nCommon Side Effects\n\nMild stomach discomfort\n\nNausea or vomiting\n\nDiarrhea\n\nHeadache\n\nIncreased urination\n\nLow blood sugar (hypoglycemia), especially when meals are skipped\n\nLess Common Side Effects\n\nUrinary tract infections\n\nDizziness or weakness\n\nMild dehydration\n\nRare but Serious Effects\n\nSevere hypoglycemia\n\nLactic acidosis (very rare but serious condition linked with metformin)\n\nAllergic reactions\n\nPatients should immediately consult a healthcare professional if they experience unusual symptoms such as severe weakness, difficulty breathing, or persistent stomach pain.\n\nPrecautions and Safety Advice\n\nBefore starting GLIDAPAFLOZIN TRIO 2, patients should inform their doctor if they have:\n\nKidney disease\n\nLiver problems\n\nHeart conditions\n\nHistory of severe dehydration\n\nAny known drug allergies\n\nPatients should also avoid skipping meals and maintain proper hydration to reduce the risk of low blood sugar.\n\nRegular monitoring of blood glucose levels is important while using this medication.\n\nLifestyle Tips for Better Results\n\nMedication alone cannot control diabetes. Patients should combine treatment with healthy habits.\n\nRecommended lifestyle practices include:\n\nMaintaining a balanced diabetic diet\n\nExercising regularly\n\nMonitoring blood sugar levels\n\nAvoiding excessive sugar and processed foods\n\nManaging stress levels\n\nGetting sufficient sleep\n\nThese lifestyle changes enhance the effectiveness of diabetes medications.\n\nConclusion\nManaging diabetes requires a consistent and comprehensive approach. Combination medicines like GLIDAPAFLOZIN TRIO 2 provide an effective solution for patients who need stronger glucose control than single-drug therapy can offer.", "price": 184.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2317, "imageuri": "https://productimages.withfloats.com/actual/69a9837cad119d5b47141190.png", "tileimageuri": "https://productimages.withfloats.com/tile/69a9837cad119d5b47141190.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-05T13:22:02.718Z", "updatedon": "2026-03-13T11:05:08.762Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-glimepiride-metformin-tablet/2317", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN TRIO 2", "category": "DIABETIC RANGE", "tags": [ "dapagliflozin glimepiride metformin tablet uses and dosage", "dapagliflozin glimepiride metformin combination tablet benefits", "dapagliflozin glimepiride metformin tablet side effects in adults", "dapagliflozin glimepiride metformin tablet how it works", "dapagliflozin glimepiride metformin tablet benefits for sugar control", "buy dapagliflozin glimepiride metformin tablet online", "dapagliflozin glimepiride metformin tablet price in india", "dapagliflozin glimepiride metformin tablet for uncontrolled diabetes", "dapagliflozin glimepiride metformin tablet triple therapy medicine", "dapagliflozin glimepiride metformin tablet dosage guide for adults" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f09d8db9fdd21801ec775", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "dapagliflozin and metformin hydrochloride extended-release", "description": "GLIDAPAFLOZIN M 10/500 \nDapagliflozin (10mg), Metformin (500mg) SR\nIntroduction\nGLIDAPAFLOZIN M 10/500 combines two potent medications, Dapagliflozin (10 mg) and Metformin (500 mg, sustained-release), into a single tablet. This formulation offers a comprehensive approach to managing Type 2 diabetes by targeting both blood glucose levels and metabolic health.\n\nMechanism of Action\n\nDapagliflozin (10 mg): Dapagliflozin is an SGLT2 inhibitor that works in the kidneys to reduce glucose reabsorption, leading to increased urinary glucose excretion. This action helps lower blood glucose levels and can also promote weight loss and cardiovascular benefits.\nMetformin (500 mg, sustained-release): Metformin is a widely used medication that improves insulin sensitivity, reduces glucose production in the liver, and decreases intestinal glucose absorption. The sustained-release formulation ensures a gradual release of Metformin, minimizing gastrointestinal side effects.\nBenefits\nGLIDAPAFLOZIN M 10/500 offers several benefits for individuals with Type 2 diabetes. By combining Dapagliflozin and Metformin, it provides dual-action control over blood glucose levels, enhances insulin sensitivity, and supports overall metabolic health. This combination can lead to improved glycemic control and may also assist in weight management.\n\nDosage and Administration\n\nDosage: The recommended dose is one tablet per day, taken with a meal. Dosage adjustments may be necessary based on individual response and tolerability.\nAdministration: GLIDAPAFLOZIN M 10/500 should be taken in the morning to maximize its effectiveness throughout the day. It is important to follow the prescribed dosing schedule consistently.\nSide Effects\nCommon side effects of GLIDAPAFLOZIN M 10/500 may include urinary tract infections, genital infections, and gastrointestinal disturbances such as nausea or diarrhea. These side effects are generally mild and transient, but patients should be aware of them and report any concerns to their healthcare provider.\n\nConclusion\nGLIDAPAFLOZIN M 10/500 is a convenient and effective option for individuals with Type 2 diabetes, offering dual-action control over blood glucose levels and metabolic health. Its combination of Dapagliflozin and Metformin provides a comprehensive approach to diabetes management, potentially leading to improved outcomes and better quality of life. Patients should consult their healthcare provider for personalized advice on dosage and monitoring.\nFor further information:\nEMAIL: info@sterispharma.com / contact@sterispharma.com \n Order Now\n", "price": 275.0, "discountamount": 82.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "SR", "day", "meal", "dose", "life", "liver", "Order", "EMAIL", "lower", "better", "500 mg", "nausea", "quality", "kidneys", "morning", "diarrhea", "concerns", "patients", "Metformin", "Mechanism", "increased", "Conclusion", "one tablet", "convenient", "monitoring", "weight loss", "combination", "information", "individuals", "Introduction", "sterisonline", "tolerability", "sterispharma", "Dapagliflozin", "single tablet", "CALL/WHATSAPP", "effectiveness", "GLIDAPAFLOZIN M", "dosing schedule", "gradual release", "SGLT2 inhibitor", "Type 2 diabetes", "several benefits", "effective option", "glycemic control", "weight management", "improved outcomes", "Dosage adjustments", "genital infections", "glucose production", "personalized advice", "diabetes management", "healthcare provider", "individual response", "dual-action control", "insulin sensitivity", "Common side effects", "blood glucose levels", "glucose reabsorption", "Administration Dosage", "two potent medications", "comprehensive approach", "cardiovascular benefits", "overall metabolic health", "urinary tract infections", "urinary glucose excretion", "gastrointestinal side effects", "intestinal glucose absorption", "gastrointestinal disturbances", "sustained-release formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1315, "imageuri": "https://productimages.withfloats.com/actual/665f09da137212f68f05951a.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f09da137212f68f05951a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:34:32.323Z", "updatedon": "2026-03-13T05:40:10.958Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-and-metformin-hydrochloride-extended-release/1315", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN M 10/500 ", "category": "DIABETIC RANGE", "tags": [ "dapagliflozin metformin hydrochloride extended-release uses", "dapagliflozin metformin XR tablet dosage for diabetes", "dapagliflozin metformin extended-release side effects", "dapagliflozin metformin XR combination benefits", "dapagliflozin metformin extended-release tablet for type 2 diabetes", "buy dapagliflozin metformin hydrochloride extended-release online", "dapagliflozin metformin XR tablet price online", "order dapagliflozin metformin extended-release tablets india", "where to buy dapagliflozin metformin XR tablets", "dapagliflozin metformin hydrochloride extended-release uses, dosage, side effects", "dapagliflozin metformin XR tablet benefits for type 2 diabetes" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a06f0051c45b26e830ddf29", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "dapagliflozin 10 vildagliptin 100 metformin 1000", "description": "Managing type 2 diabetes effectively requires the right combination of medicines, healthy eating habits, and an active lifestyle. Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets is a powerful triple-combination anti-diabetic medication designed to help control blood sugar levels in adults suffering from type 2 diabetes mellitus. This advanced formulation combines three clinically trusted medicines in one tablet to improve glycemic control and support long-term diabetic management.\n\nThis combination is commonly prescribed when blood sugar levels are not adequately controlled with a single medicine or dual therapy. It helps patients achieve better glucose regulation while reducing the risk of diabetes-related complications.\n\nWhat is Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets?\n\nDapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets is a combination medication used for the treatment of Type 2 Diabetes Mellitus. It contains:\n\nDapagliflozin 10 mg\nVildagliptin SR 100 mg\nMetformin SR 1000 mg\n\nEach ingredient works through a different mechanism to provide comprehensive blood sugar control.\n\nThis medicine is generally recommended along with proper diet and exercise to improve overall diabetic management and reduce insulin resistance.\n\nComposition of Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets\n1. Dapagliflozin 10 mg\n\nDapagliflozin belongs to the SGLT2 inhibitor class of medicines. It works by removing excess glucose from the body through urine. This helps lower blood sugar levels naturally.\n\n2. Vildagliptin SR 100 mg\n\nVildagliptin is a DPP-4 inhibitor that increases incretin hormone levels in the body. These hormones help regulate insulin secretion and reduce glucose production by the liver.\n\n3. Metformin SR 1000 mg\n\nMetformin is one of the most trusted anti-diabetic medicines worldwide. It reduces glucose production in the liver and improves insulin sensitivity in the body.\n\nThe sustained-release (SR) formulation ensures gradual release of medicine for long-lasting action and better patient compliance.\n\nHow Do Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets Work?\n\nThis triple combination provides multidimensional control over blood sugar levels.\n\nDapagliflozin Works By:\nRemoving excess sugar through urine\nLowering fasting blood glucose\nSupporting weight management\nVildagliptin Works By:\nIncreasing insulin release after meals\nReducing glucagon secretion\nImproving pancreatic function\nMetformin Works By:\nReducing liver glucose production\nImproving insulin sensitivity\nLowering intestinal glucose absorption\n\nTogether, these medicines help maintain stable blood glucose levels throughout the day.\n\nBenefits of Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets\nEffective Blood Sugar Control\n\nThe combination targets multiple pathways involved in diabetes, helping achieve better glycemic control.\n\nReduced Risk of Diabetes Complications\n\nProper diabetes management lowers the risk of:\n\nKidney problems\nNerve damage\nHeart disease\nVision complications\nWeight Management Support\n\nDapagliflozin helps remove excess glucose, which may contribute to mild weight reduction in some patients.\n\nImproved Insulin Sensitivity\n\nMetformin enhances insulin utilization by body tissues.\n\nBetter Patient Compliance\n\nThree medicines in a single tablet reduce pill burden and simplify treatment.\n\nSustained Release Formula\n\nThe SR formulation provides extended therapeutic action and minimizes fluctuations in blood sugar levels.\n\nUses of Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets\n\nThis medicine is mainly prescribed for:\n\nType 2 Diabetes Mellitus\nUncontrolled diabetes despite dual therapy\nPatients requiring triple-drug glucose control\nImproving HbA1c levels\nManaging post-meal blood sugar spikes\n\nIt is generally not recommended for type 1 diabetes unless specifically advised by a healthcare professional.\n\nWho Can Take This Medicine?\n\nDapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg tablets may be suitable for:\n\nAdults diagnosed with type 2 diabetes\nPatients with insulin resistance\nIndividuals requiring combination diabetic therapy\nPatients seeking convenient once-daily diabetic medication\n\nAlways use this medicine under medical supervision.\n\nDosage and Administration\nTake the tablet exactly as prescribed by your doctor.\nUsually taken once daily with meals.\nSwallow the tablet whole with water.\nDo not crush or chew sustained-release tablets.\nFollow dietary recommendations for best results.\n\nDosage may vary depending on blood sugar levels and patient response.\n\nPossible Side Effects\n\nLike all medicines, Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg tablets may cause some side effects.\n\nCommon Side Effects\nNausea\nDiarrhea\nFrequent urination\nHeadache\nStomach discomfort\nWeakness\nLess Common Side Effects\nUrinary tract infections\nGenital fungal infections\nDizziness\nLow blood sugar (especially with other anti-diabetic medicines)\nSerious Side Effects\n\nSeek immediate medical attention if you experience:\n\nSevere dehydration\nDifficulty breathing\nSevere abdominal pain\nSigns of allergic reaction\nPersistent vomiting\n\nMost side effects are mild and improve as the body adjusts to the medicine.\n\nPrecautions and Warnings\n\nBefore taking this medicine, inform your doctor if you have:\n\nKidney disease\nLiver disorders\nHeart disease\nHistory of pancreatitis\nDehydration issues\nAlcohol dependence\nImportant Precautions\nStay hydrated while taking dapagliflozin.\nMonitor blood sugar regularly.\nAvoid excessive alcohol consumption.\nFollow a diabetic-friendly diet.\n\nPregnant and breastfeeding women should consult a doctor before use.\n\nDrug Interactions\n\nThis medicine may interact with:\n\nInsulin\nSulfonylureas\nDiuretics\nBlood pressure medicines\nCorticosteroids\n\nAlways inform your doctor about all medications and supplements you are taking.\n\nStorage Instructions\nStore in a cool and dry place.\nKeep away from direct sunlight and moisture.\nStore below recommended room temperature.\nKeep out of reach of children.\n\nProper storage ensures medicine effectiveness and safety.\n\nWhy Choose Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg Tablets?\n\nThis advanced antidiabetic combination offers:\n\nTriple-action diabetes management\nLong-lasting blood sugar control\nConvenient dosing\nImproved patient adherence\nComprehensive glycemic regulation\n\nIt is widely preferred by healthcare professionals for patients requiring strong and reliable diabetic treatment.\n\nLifestyle Tips for Better Diabetes Management\n\nAlong with medication, patients should:\n\nMaintain a balanced diabetic diet\nExercise regularly\nMonitor blood glucose levels\nStay hydrated\nAvoid sugary foods\nFollow regular medical checkups\n\nHealthy lifestyle changes significantly improve treatment outcomes.\n\nFrequently Asked Questions\nIs Dapagliflozin 10 mg, Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets safe for long-term use?\n\nYes, when taken under medical supervision, it is generally considered safe for long-term diabetes management.\n\nCan this medicine help reduce HbA1c levels?\n\nYes, this combination is effective in lowering HbA1c and maintaining blood sugar control.\n\nDoes this medicine cause weight gain?\n\nDapagliflozin may support mild weight reduction in some patients.\n\nCan I stop the medicine once sugar levels improve?\n\nDo not stop taking the medicine without consulting your doctor.\n\nIs this medicine suitable for elderly patients?\n\nIt may be prescribed to elderly patients after proper medical evaluation.\n\nConclusion\n\nDapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg tablets are a highly effective triple-combination therapy for managing type 2 diabetes mellitus. By combining the benefits of dapagliflozin, vildagliptin, and metformin SR, this medicine provides comprehensive blood sugar control, improves insulin sensitivity, and helps reduce diabetes-related complications.", "price": 375.0, "discountamount": 113.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2422, "imageuri": "https://productimages.withfloats.com/actual/6a06f00b91493d06f6e7fcdf.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a06f00b91493d06f6e7fcdf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-05-15T10:05:57.462Z", "updatedon": "2026-06-05T07:31:14.082Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-10-vildagliptin-100-metformin-1000/2422", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DAPAVILDA MET 10/100/1000", "category": "DIABETIC RANGE", "tags": [ "dapagliflozin 10 vildagliptin 100 metformin 1000", "dapagliflozin vildagliptin metformin", "dapagliflozin vildagliptin metformin combination", "dapagliflozin vildagliptin metformin 1000", "Dapagliflozin + Vildagliptin + Metformin Tablets", "Buy Dapagliflozin + Vildagliptin + Metformin Tablets Online", "Type 2 Diabetes Treatment Tablets", "Blood Sugar Control Medicine with Dapagliflozin, Vildagliptin & Metformin", "Triple Combination Anti-Diabetic Tablets", "Best Diabetes Control Tablets for Type 2 Diabetes", "Prescription Anti-Diabetic Medicine Tablets", "Dapagliflozin 10 mg Vildagliptin 100 mg Metformin 1000 mg Product Image", "Premium Quality Diabetic Care Tablets", "Combination Diabetes Medicine for Glycemic Control", "Type 2 Diabetes Management Tablets Online", "Advanced Blood Sugar Control Tablets", "Dapagliflozin Vildagliptin Metformin Tablets Supplier in India", "Dapagliflozin Vildagliptin Metformin Tablets Manufacturer in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69e8b6d9c44d63abc6fde1be", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "paroxetine prolonged release tablets ip", "description": "Paroxetine Prolonged Release Tablets IP\n\nWhen dealing with mental health conditions such as depression, anxiety, or panic disorders, choosing the right medication is crucial for long-term stability and improved quality of life. Paroxetine Prolonged Release Tablets IP is a widely prescribed medication that offers controlled, sustained relief for individuals struggling with various mood and anxiety-related disorders.\n\nThis detailed buyer-intent guide is designed to help patients, caregivers, and healthcare buyers understand the uses, benefits, working mechanism, dosage, and important precautions associated with Paroxetine Prolonged Release Tablets IP.\n\nWhat is Paroxetine Prolonged Release Tablets IP?\n\nParoxetine Prolonged Release Tablets IP contains paroxetine, a selective serotonin reuptake inhibitor (SSRI). It is specifically formulated in a prolonged-release (controlled-release) form, which allows the medication to be released gradually in the body over time.\n\nThis ensures:\n\nStable blood levels of the drug\nReduced dosing frequency\nImproved patient compliance\nFewer fluctuations in therapeutic effect\n\nIt is commonly prescribed for managing a range of psychiatric conditions, including depression and anxiety disorders.\n\nHow Does Paroxetine Prolonged Release Tablets IP Work?\n\nParoxetine works by increasing the levels of serotonin, a neurotransmitter in the brain that plays a key role in mood regulation, emotional balance, and mental well-being.\n\nMechanism of Action:\nBlocks the reabsorption (reuptake) of serotonin in the brain\nEnhances serotonin availability between nerve cells\nImproves communication between neurons\nStabilizes mood and reduces anxiety symptoms\nWhy Prolonged Release Matters:\n\nThe prolonged-release formulation ensures a steady release of medication throughout the day, minimizing side effects and maintaining consistent symptom control.\n\nKey Benefits of Paroxetine Prolonged Release Tablets IP\n1. Effective Treatment for Depression\n\nHelps reduce persistent sadness, low energy, and loss of interest in daily activities.\n\n2. Controls Anxiety Disorders\n\nHighly effective in treating generalized anxiety disorder (GAD), social anxiety, and panic disorder.\n\n3. Improves Emotional Stability\n\nSupports better mood regulation and reduces emotional fluctuations.\n\n4. Once-Daily Convenience\n\nThe prolonged-release formula allows for easy once-daily dosing.\n\n5. Better Tolerability\n\nGradual drug release reduces the risk of sudden side effects compared to immediate-release formulations.\n\nCommon Uses of Paroxetine Prolonged Release Tablets IP\n\nThis medication is prescribed for:\n\nMajor depressive disorder (MDD)\nGeneralized anxiety disorder (GAD)\nPanic disorder\nSocial anxiety disorder\nObsessive-compulsive disorder (OCD)\nPost-traumatic stress disorder (PTSD)\n\nIt is also sometimes used for other conditions based on a doctor’s recommendation.\n\nWho Should Consider Buying Paroxetine Prolonged Release Tablets IP?\n\nThis medication may be suitable for:\n\nIndividuals diagnosed with depression or anxiety disorders\nPatients needing long-term psychiatric management\nThose who prefer once-daily medication for better compliance\nIndividuals who experience side effects with immediate-release SSRIs\n\nImportant: This medication should only be used under a doctor’s prescription and supervision.\n\nDosage and Administration\n\nThe dosage of Paroxetine Prolonged Release Tablets IP depends on the condition being treated and the patient’s response.\n\nGeneral Guidelines:\nTypically taken once daily, usually in the morning\nSwallow the tablet whole with water\nDo not crush, chew, or break the tablet\nDosage Tips:\nStart with a lower dose and increase gradually as advised\nTake the medicine at the same time every day\nDo not skip doses or stop suddenly\nPossible Side Effects\n\nLike all medications, Paroxetine Prolonged Release Tablets IP may cause side effects.\n\nCommon Side Effects:\nNausea\nDrowsiness or fatigue\nDry mouth\nDizziness\nSweating\nLess Common but Serious Side Effects:\nSuicidal thoughts (especially in young adults)\nSevere mood changes\nSerotonin syndrome (rare but serious)\nSexual dysfunction\nWeight changes\n\nIf you experience severe or unusual symptoms, seek medical help immediately.\n\nPrecautions and Warnings\n\nBefore starting this medication, consider the following:\n\nMedical Conditions:\nInform your doctor if you have liver or kidney disease\nPatients with a history of seizures should use caution\nAvoid use in individuals with bipolar disorder without supervision\nPregnancy and Breastfeeding:\nUse only if prescribed\nDiscuss potential risks and benefits with your doctor\nDrug Interactions:\n\nParoxetine may interact with:\n\nMonoamine oxidase inhibitors (MAOIs)\nBlood thinners\nOther antidepressants\nAnti-anxiety medications\n\nAlways inform your healthcare provider about all medications and supplements you are taking.\n\nStorage Instructions\n\nTo maintain effectiveness:\n\nStore in a cool, dry place\nKeep away from direct sunlight\nMaintain temperature below 25°C\nKeep out of reach of children\nBuying Guide: What to Check Before Purchase\n\nWhen purchasing Paroxetine Prolonged Release Tablets IP, ensure the following:\n\nIt is prescribed by a qualified doctor\nThe product is from a trusted pharmaceutical brand\nPackaging is sealed and undamaged\nExpiry date is valid\nPurchased from a licensed pharmacy\n\nFor distributors or bulk buyers, sourcing from reliable manufacturers ensures quality and consistency.\n\nWhy Choose Paroxetine Prolonged Release Tablets IP?\n\nThis medication stands out because of the following:\n\nProven effectiveness in mental health treatment\nControlled-release technology for consistent results\nImproved patient compliance with once-daily dosing\nReduced side effects compared to immediate-release forms\nWidely trusted by healthcare professionals\n\nFor individuals seeking reliable and long-term management of depression and anxiety, this medication is a strong and dependable choice.\n\nFrequently Asked Questions (FAQs)\n1. How long does it take to work?\n\nIt may take 2–4 weeks to notice improvement, with full benefits appearing after several weeks.\n\n2. Can I stop taking it once I feel better?\n\nNo, stopping suddenly can cause withdrawal symptoms. Always consult your doctor.\n\n3. Is it addictive?\n\nNo, but it should be taken as prescribed to avoid dependency-like withdrawal symptoms.\n\n4. Can I take it at night?\n\nIt is usually taken in the morning, but your doctor may adjust timing based on your condition.\n\n5. Does it affect sleep?\n\nIt may cause drowsiness or insomnia in some individuals.\n\nLifestyle Tips for Better Results\n\nTo enhance the effectiveness of Paroxetine:\n\nMaintain a regular sleep schedule\nPractice stress management techniques (yoga, meditation)\nEat a balanced diet\nAvoid alcohol and recreational drugs\nStay physically active\nConclusion\n\nParoxetine Prolonged Release Tablets IP is a highly effective and well-established medication for managing depression, anxiety, and other mental health conditions. Its prolonged-release formulation ensures steady symptom control, improved tolerability, and better patient compliance.\n\nFor best results, always use this medication under medical supervision, follow the prescribed dosage, and combine it with a healthy lifestyle. With the right approach, it can significantly improve emotional well-being and overall quality of life.", "price": 340.0, "discountamount": 102.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2386, "imageuri": "https://productimages.withfloats.com/actual/69e8b716cd1d55c59bd1b04b.png", "tileimageuri": "https://productimages.withfloats.com/tile/69e8b716cd1d55c59bd1b04b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-22T11:54:01.282Z", "updatedon": "2026-05-20T12:03:10.275Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//paroxetine-prolonged-release-tablets-ip/2386", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PAROXTIME CR 37.5", "category": "NEUROLOGY RANGE", "tags": [ "paroxetine prolonged release tablets", "paroxetine prolonged release tablets uses", "paroxetine prolonged release tablets ip", "paroxetine prolonged release tablets in hindi", "rx paroxetine prolonged release tablets", "paroxetine prolonged release tablets side effects", "use of paroxetine prolonged release tablets", "Paroxetine Prolonged Release Tablets 37.5 mg", "paroxetine prolonged release tablets 37.5 mg price in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694e56c05837f90c86a7eb8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin linagliptin and metformin", "description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n​\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n​\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n​\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n​\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n​\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n​\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n​\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n​\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n​\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n​\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n​\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n​\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n​\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n​\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n​\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n​\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n​\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n​\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n​\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n​\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n​\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n​\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n​\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n​\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n​\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n​\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n​\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.", "price": 220.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2257, "imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png", "tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-26T09:34:56.604Z", "updatedon": "2026-03-13T10:59:31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-linagliptin-and-metformin/2257", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGIP EMPAMET", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 10 mg", "empagliflozin 25 mg", "empagliflozin 10 mg uses in hindi", "empagliflozin 10 mg tablet.", "type 2 diabetes mellitus.", "linagliptin", "Linagliptin 5 mg", "linagliptin 5 mg uses", "linagliptin tablet uses", "Linagliptin 5 mg price", "Empagliflozin, an SGLT2 inhibitor.", "Metformin ER reduces hepatic glucose production and improves insulin.", "LINALIGIP EMPAMET revolutionizes type 2 diabetes.", "empagliflozin linagliptin and metformin tablets", "empagliflozin linagliptin metformin combination tablet", "empagliflozin linagliptin metformin tablets uses", "empagliflozin linagliptin metformin triple combination", "empagliflozin linagliptin metformin dosage strength", "empagliflozin linagliptin metformin sustained release tablet", "empagliflozin linagliptin metformin medicine for diabetes", "empagliflozin linagliptin metformin tablet uses", "empagliflozin linagliptin metformin benefits", "empagliflozin linagliptin metformin for type 2 diabetes", "empagliflozin linagliptin metformin blood sugar control", "empagliflozin linagliptin metformin weight loss benefit", "what is empagliflozin linagliptin metformin tablet", "how does empagliflozin linagliptin metformin work", "empagliflozin linagliptin metformin tablet price in india", "empagliflozin linagliptin metformin tablet dosage", "empagliflozin linagliptin metformin before or after food" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694919f0de5d3e57a93413a8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "elagolix 150mg tablet", "description": "Eligolux 150 delivers 150mg of elagolix per tablet, formulated as an oral, once-daily option in convenient packs for ongoing therapy. As a non-peptide GnRH receptor antagonist, it selectively suppresses pituitary gonadotropins, reducing ovarian estrogen production without the flare effect of agonists. Ideal for patients with milder symptoms or those prioritizing bone health, this dose minimizes hypoestrogenic risks while targeting endometriotic pain.\n\nTake Eligolux 150 whole with water, with or without food, preferably at the same time daily. Storage requires a cool, dry environment below 30°C, away from children and moisture. Steris Healthcare ensures GMP-compliant manufacturing, making it accessible across India for endometriosis care.\n\nPrimary Uses and Indications\nEligolux 150 primarily treats moderate endometriosis-associated pain, including dysmenorrhea, chronic pelvic discomfort, and dyspareunia. Endometriosis impacts 10% of reproductive-age women, causing ectopic endometrial growth that triggers inflammation and scarring; elagolix 150mg curbs estrogen-driven progression.\n​\nPrescribed when NSAIDs or combined pills prove inadequate, it excels in non-severe cases, allowing prolonged use. Emerging evidence supports its role in heavy menstrual bleeding from fibroids, though primary approval focuses on pain relief. Start therapy within the first week of menses for optimal synchronization.\n​\nMechanism of Action\nElagolix in Eligolux 150 competitively binds GnRH receptors, dose-dependently inhibiting LH/FSH release. This lowers estradiol by 40-60%—less aggressive than 200mg—halting endometrial tissue proliferation outside the uterus. Peak levels hit in 1 hour, with a 4-6 hour half-life supporting steady-state suppression on QD dosing.\n​\nUnlike agonists, no initial hormone surge occurs, preventing worsened pain. Partial estrogen reduction preserves some bone-protective effects, differentiating it from deeper suppression therapies.\n\nKey Benefits\nEligolux 150 shines in clinical responsiveness: phase 3 trials showed 32% dysmenorrhea resolution versus 20% placebo at 6 months, with 50% pain score drops. Quality-of-life gains include better work attendance, sleep, and relationships, per EQ-5D assessments.\n​\nExtended 24-month approval suits long-term control, with amenorrhea in 40-50% of users reducing bleeding volume by 70%. Oral ease beats injectables, enhancing adherence at 85% in studies. Lower BMD impact (0.5-1% loss/year) allows safer continuation versus higher doses.\n\nBenefit\tTrial Data\tPatient Impact\nPain Reduction\t32-50% dysmenorrhea-free \n​\tDaily activity restoration\nBleeding Control\t70% volume drop \n​\tAnemia prevention\nLong-Term Use:\tUp to 24 months \n​\tSustained relief\nQoL Improvement\tEQ-5D gains \n​\tEmotional well-being\nPotential Side Effects\nVasomotor symptoms dominate: hot flashes (20-30%), headaches (17%), and night sweats (10-15%) emerge early but fade. Nausea (8%), insomnia (7%), and mild depression (5%) affect minorities, with a 70% event rate mostly grade 1.\n​\nBMD decline averages -0.9% at the spine after 12 months, monitored via DEXA. Discontinuation hovers at 5-8%.\n\nSide Effect\tIncidence\tMitigation\nHot Flashes\t20-30% \n​\tVentilation, timing\nHeadache\t17% \n​\tAnalgesics\nBMD Loss\t0.9% \n​\tSupplements, scans\nMood Shifts\t5% \n​\tMonitoring\nSerious Risks and Management\nSuicidality (0.1-0.5%) demands baseline psych screening; halt if worsening. Liver enzymes rise in 1%, requiring LFTs at 3/6 months. Rare anaphylaxis or thromboembolism prompts immediate cessation. Avoid in osteoporosis or smokers >35.\n​\n\nDosage Guidelines\n150 mg once daily for up to 24 months in normal/mild liver function; limit to 6 months in moderate impairment (Child-Pugh B). No titration needed; miss a dose? Resume the next day, no doubling. Pair with 1 g calcium/800 IU vitamin D daily.\n​\n\nPrecautions and Contraindications\nPregnancy category X: mandates non-hormonal birth control during and 1 week post-therapy. Screen hepatic/renal function; avoid severe cases. CYP3A interactions (e.g., rifampin reduces efficacy) need dose review. Breastfeeding is contraindicated.\n​\nClinical Evidence and Efficacy\nElaris trials (n=1,689) confirmed superiority: co-primary endpoints met with 75% responder rates for pain. 12-month extensions showed persistent efficacy and low rebound. Versus 200mg, 150mg balances tolerability for moderate pain.\n​\nConclusion\nEligolux 150 empowers women with moderate endometriosis pain through precise, extended hormonal modulation and proven outcomes. Regular physician oversight maximizes safety and efficacy.\n", "price": 700.0, "discountamount": 210.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2252, "imageuri": "https://productimages.withfloats.com/actual/694a2af01e4092f757d90bb5.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2af01e4092f757d90bb5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T10:14:08.773Z", "updatedon": "2026-03-26T05:59:45.544Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//elagolix-150mg-tablet/2252", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 150", "category": "GYANECOLOGYRANGE", "tags": [ "elagolix 150mg tablet", "prioritizing bone health.", "endometriotic pain.", "endometrial tissue proliferation outside the uterus.", "Eligolux 150 empowers women with moderate endometriosis pain through precise.", "hormonal modulation and proven outcomes.", "gonadotropins.", "endometriotic pain." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "glimepiride voglibose metformin", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/69abe998ad5b8f3f9ba863c2.png", "tileimageuri": "https://productimages.withfloats.com/tile/69abe998ad5b8f3f9ba863c2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2026-03-13T10:35:41.824Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glimepiride-voglibose-metformin/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "DIABETIC RANGE", "tags": [ "glimepiride voglibose metformin tablets", "glimepiride voglibose metformin combination", "glimepiride voglibose metformin dosage", "glimepiride voglibose metformin uses", "glimepiride voglibose metformin composition", "glimepiride voglibose metformin tablets ip", "glimepiride voglibose metformin triple combination", "glimepiride voglibose metformin for type 2 diabetes", "triple drug combination for type 2 diabetes", "diabetes medicine for high fasting and pp sugar", "medicine for uncontrolled diabetes type 2", "combination tablets for diabetes management", "combination tablets for diabetes management", "when to take glimepiride voglibose metformin tablets", "who should take glimepiride voglibose metformin", "benefits of glimepiride voglibose metformin tablets", "side effects of glimepiride voglibose metformin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }